{"created":"2023-07-25T10:25:10.656522+00:00","id":5375,"links":{},"metadata":{"_buckets":{"deposit":"d5f1959a-44ec-4dfe-89c4-97596d85cec7"},"_deposit":{"created_by":15,"id":"5375","owners":[15],"pid":{"revision_id":0,"type":"depid","value":"5375"},"status":"published"},"_oai":{"id":"oai:air.repo.nii.ac.jp:00005375","sets":["611:968:969:1383"]},"author_link":["14986"],"item_10006_alternative_title_32":{"attribute_name":"別タイトル","attribute_value_mlt":[{"subitem_alternative_title":"ABCG2 C421A遺伝子多型はEGFR阻害薬gefitinibの血中濃度に影響する"}]},"item_10006_biblio_info_34":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2021-03-22","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{}]}]},"item_10006_date_granted_41":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2021-03-22"}]},"item_10006_degree_grantor_40":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_name":"秋田大学"}]}]},"item_10006_degree_name_39":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）"}]},"item_10006_dissertation_number_42":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"11401甲第1377号"}]},"item_10006_publisher_28":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"秋田大学"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"坂本, 祥"}],"nameIdentifiers":[{"nameIdentifier":"14986","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-06-02"}],"displaytype":"detail","filename":"ihakuyoushikou1377.pdf","filesize":[{"value":"421.0 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"内容要旨及び審査結果要旨","url":"https://air.repo.nii.ac.jp/record/5375/files/ihakuyoushikou1377.pdf"},"version_id":"298fa4ac-3e17-45bc-92e0-6fd35f4d19a4"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"thesis","resourceuri":"http://purl.org/coar/resource_type/c_46ec"}]},"item_title":"ABCG2 C421A polymorphisms affect exposure of the epidermal growth factor receptor inhibitor gefitinib","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"ABCG2 C421A polymorphisms affect exposure of the epidermal growth factor receptor inhibitor gefitinib"}]},"item_type_id":"10006","owner":"15","path":["1383"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-06-02"},"publish_date":"2021-06-02","publish_status":"0","recid":"5375","relation_version_is_last":true,"title":["ABCG2 C421A polymorphisms affect exposure of the epidermal growth factor receptor inhibitor gefitinib"],"weko_creator_id":"15","weko_shared_id":-1},"updated":"2023-07-25T10:53:26.958046+00:00"}